Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,869 | 8,926 | 11,151 | 12,941 | 3,926 |
| Receivables | N/A | N/A | N/A | N/A | 115 |
| TOTAL | $7,912 | $9,022 | $11,255 | $12,985 | $4,082 |
| Non-Current Assets | |||||
| PPE Net | 235 | 260 | 300 | 322 | 352 |
| Intangibles | 989 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 376 | 380 | 380 | 480 | 1,043 |
| TOTAL | $1,600 | $640 | $680 | $802 | $1,394 |
| Total Assets | $9,512 | $9,662 | $11,935 | $13,787 | $5,476 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 598 | 807 | 1,007 | 1,576 | 2,301 |
| Accrued Expenses | 748 | 620 | 909 | 349 | 337 |
| Other current liabilities | 573 | 3,452 | 2,259 | 4,366 | 4,803 |
| TOTAL | $1,919 | $4,879 | $4,175 | $6,290 | $7,440 |
| Non-Current Liabilities | |||||
| TOTAL | $165 | $172 | $180 | $188 | $190 |
| Total Liabilities | $2,084 | $5,051 | $4,355 | $6,477 | $7,630 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,155 | 3,928 | 3,893 | 3,893 | 3,893 |
| Common Shares | 8 | 8 | 8 | 8 | 6 |
| Retained earnings | -80,962 | -81,405 | -77,956 | -77,266 | -76,226 |
| TOTAL | $7,428 | $4,611 | $7,580 | $7,310 | $-2,155 |
| Total Liabilities And Equity | $9,512 | $9,662 | $11,935 | $13,788 | $5,476 |